Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Alexion Pharmaceuticals revenue
Alexion Pharmaceuticals's revenue is $6.1 billion.
What is Alexion Pharmaceuticals's revenue?
- Alexion Pharmaceuticals's revenue growth from 2001 to 2020 is 51,318.04%.
- Alexion Pharmaceuticals has 2,525 employees, and the revenue per employee ratio is $2,403,920.
- Alexion Pharmaceuticals's peak quarterly revenue was $1.6B in 2021(q1).
- Alexion Pharmaceuticals peak revenue was $6.1B in 2020.
- Alexion Pharmaceuticals annual revenue for 2019 was 5.0B, 20.81% growth from 2018.
- Alexion Pharmaceuticals annual revenue for 2020 was 6.1B, 21.61% growth from 2019.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Alexion Pharmaceuticals historical revenue
Alexion Pharmaceuticals's peak revenue was $6.1B in 2020. The peak quarterly revenue was $1.6B in 2021(q1).
Alexion Pharmaceuticals's revenue increased from $11.8m in 2001 to $6.1B currently. That's a 51,318.04% change in annual revenue.
Alexion Pharmaceuticals annual revenue
Alexion Pharmaceuticals annual revenue over time
| Fiscal year / year | Alexion Pharmaceuticals revenue |
|---|---|
| 2009 | $386.8M |
| 2010 | $541.0M |
| 2011 | $783.4M |
| 2012 | $1.1B |
| 2013 | $1.6B |
| 2014 | $2.2B |
| 2015 | $2.6B |
| 2016 | $3.1B |
| 2017 | $3.6B |
| 2018 | $4.1B |
| 2019 | $5.0B |
| 2020 | $6.1B |
Rate Alexion Pharmaceuticals' financial transparency
Alexion Pharmaceuticals annual growth
Alexion Pharmaceuticals saw the greatest revenue growth in 2007, when revenue increased by 4,523.94%.
Alexion Pharmaceuticals had the lowest revenue growth in 2003, when revenue changed by -86.58%.
Alexion Pharmaceuticals annual growth rate over time
| Year | Alexion Pharmaceuticals growth |
|---|---|
| 2009 | 49%↑ |
| 2010 | 40%↑ |
| 2011 | 45%↑ |
| 2012 | 45%↑ |
| 2013 | 37%↑ |
| 2014 | 44%↑ |
| 2015 | 17%↑ |
| 2016 | 18%↑ |
| 2017 | 15%↑ |
| 2018 | 16%↑ |
| 2019 | 21%↑ |
| 2020 | 22%↑ |
Alexion Pharmaceuticals quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Alexion Pharmaceuticals quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $81.3M | $92.3M | $102.6M | $110.6M |
| 2010 | $117.6M | $125.8M | $141.6M | $156.0M |
| 2011 | $166.1M | $185.7M | $204.0M | $227.6M |
| 2012 | $244.7M | $274.7M | $294.1M | $320.5M |
| 2013 | $338.9M | $370.1M | $400.4M | $441.9M |
| 2014 | $566.6M | $512.5M | $555.1M | $599.7M |
| 2015 | $600.3M | $636.2M | $666.6M | $700.8M |
| 2016 | $701.0M | $753.0M | $799.0M | $831.1M |
| 2017 | $869.6M | $912.7M | $859.1M | $909.7M |
| 2018 | $930.9M | $1.0B | $1.0B | $1.1B |
| 2019 | $1.1B | $1.2B | $1.3B | $1.4B |
| 2020 | $1.4B | $1.4B | $1.6B | $1.6B |
| 2021 | $1.6B | - | - | - |
Alexion Pharmaceuticals jobs nearby
Do you work at Alexion Pharmaceuticals?
Is Alexion Pharmaceuticals transparent about its revenue structure?
Alexion Pharmaceuticals financial information
| CEO | Marc Dunoyer |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 2,525 |
| Date Founded | 1992 |
| Headquarters | Boston, Massachusetts |
| Number of Locations | 3 |
| Revenue | $6.1B |
| Net Income | $603,400,000 |
| Gross Proft | $5.5B (2020) |
| Tax Rate | -0.1% |
| Total Assets | $18,103,000,000 |
| Ticker | ALXN |
Alexion Pharmaceuticals jobs you might like
Alexion Pharmaceuticals financing
Alexion Pharmaceuticals received early financing of $5.8M on 1999-02-12.
| Series | Round size | Date |
|---|---|---|
| Post-IPO Equity - Alexion Pharmaceuticals | $5.8M | 02/1999 |
Alexion Pharmaceuticals competitors
Alexion Pharmaceuticals's top competitor, Pfizer, earned an annual revenue of $63.6B.
Alexion Pharmaceuticals's smallest competitor is Hoffmann-LA Roche Inc with revenue of $60.9B last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Regeneron | $85,589 | $14.2B | 9,123 | 390 |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 294 |
| Sunovion Pharmaceuticals | $67,270 | $600.0M | 2,400 | 20 |
| Pfizer | $70,868 | $63.6B | 78,500 | 576 |
| Octagon Research Solutions | $65,286 | $1.1M | 50 | - |
| Shire Pharmaceuticals Inc | $74,347 | $15.2B | 3,500 | - |
| Cyberonics | $86,285 | $291.6M | 660 | - |
| Nanotherapeutics, Inc. | $71,678 | - | - | - |
| Incyte | $103,592 | $4.2B | 1,600 | 48 |
| Azzur Group | $83,336 | $3.0M | 266 | - |
Alexion Pharmaceuticals revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Alexion Pharmaceuticals highest paying jobs
Zippia gives an in-depth look into the details of Alexion Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Alexion Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Alexion Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Alexion Pharmaceuticals. The data presented on this page does not represent the view of Alexion Pharmaceuticals and its employees or that of Zippia.
Alexion Pharmaceuticals may also be known as or be related to Alexion, Alexion Pharmaceuticals, Alexion Pharmaceuticals Inc, Alexion Pharmaceuticals Inc. and Alexion Pharmaceuticals, Inc.